Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company. The board comprises executive, non-executive, and independent non-executive directors, each serving on various committees such as the Audit, Remuneration and Appraisal, Nomination, and Scientific Committees. This announcement provides clarity on the governance structure of TYK Medicines, potentially impacting its strategic direction and operational efficiency.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 2,740,401
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.58B
See more data about 2410 stock on TipRanks’ Stock Analysis page.